Editorial
Jul 18
Philippe Pibarot, Eric Van Belle
This study compares the long-term durability of balloon-expandable and self-expanding transcatheter heart valves, highlighting the need for long-term outcome data and ongoing research to enhance valve durability.
free
Original Research
Jul 17
Akash Jain, Ignacio J. Amat-Santos, et al.
The study evaluated the 4-year durability of the Myval series, a balloon-expandable TAVI system, and found acceptable valve durability, low haemodynamic deterioration, and comparable performance to contemporary TAVI systems.
Expert Review
Jul 16
Xiang Chen, Maurizio Taramasso, et al.
The article discusses the growing use of robotics in cardiovascular surgery and interventions, with a focus on the potential application in structural heart interventions, highlighting both the advantages and challenges.
Original Research
Jul 15
Masanori Yamamoto, Kentaro Hayashida, et al.
This retrospective study compared early clinical outcomes, including echocardiographic parameters, between intra-annular and supra-annular self-expanding valves after TAVI in patients with small aortic annulus, finding similar results except for slightly higher mean pressure gradient with intra-annular valves.
Editorial
Jul 15
Liesbeth Rosseel, Ole De Backer, et al.
This study compared the performance of the intra-annular Navitor and supra-annular Evolut FX transcatheter aortic valves in patients with small aortic annuli, finding no significant differences in short-term valve hemodynamics and clinical outcomes.
free
Research Correspondence
Jul 11
Kazuki Matsuda, Tetsuo Sasano, et al.
This retrospective, observational study examined the underlying morphological findings in lesions treated with target lesion revascularization after initial drug-coated balloon treatment for de novo coronary artery disease.
Editorial
Jul 10
George Dangas, Johny Nicolas
TAVI can lead to cerebral microembolization and new lesions on DW-MRI. Current single antiplatelet therapy may not be optimal for all patients, and future research should explore personalized antithrombotic strategies and embolic protection devices.
free
Meet Cory, your AI Assistant!
Learn more
Enhance your reading experience and get deeper insights on complex topics.
Flashlight
Jul 7
Maximilian Will, Konstantin Schwarz, et al.
A 74-year-old male with heart failure and left ventricular ejection fraction of 40% presented with exertional chest pain and dyspnea. Coronary angiography revealed a chronic total occlusion in a large side branch of the left anterior descending artery, which was successfully treated using the 'stone whisper technique' of intravascular lithotripsy.
Original Research
Jul 9
Victor Alfonso Jimenez Diaz, Andres Iñiguez Romo, et al.
In patients without indication for oral anticoagulation undergoing TAVI, dual antiplatelet therapy did not reduce the incidence of new cerebral lesions on MRI compared to oral anticoagulation, but resulted in smaller lesion volumes.
Debate
Jul 8
Kevin R. Bainey, Xavier Rossello
A large randomized clinical trial in patients with myocardial infarction yielded neutral results for the use of colchicine, raising concerns about its true clinical benefit in patients with atherosclerotic cardiovascular disease.
NEW ISSUE
Jul 7
Robotics in structural heart interventions; debating colchicine recommendations; the AUREA trial; intra- vs supra-annular self-expanding valves in small aortic annuli; Myval durability at 4 years; restenosis patterns after drug-coated balloon PCI; news from the EAPCI; and more...
Letter to the Editor
Jul 4
Claudio Laudani, Davide Capodanno, et al.
This manuscript discusses the challenges in assessing the impact of complete revascularization in STEMI patients, highlighting the limitations of available data and the importance of considering disease complexity.
free
Letter to the Editor
Jul 3
Alessandro Sticchi, Giuseppe Biondi-Zoccai
The study by Laudani et al. examined complete revascularization strategies in acute myocardial infarction with multivessel disease, but the authors raise concerns about the potential dilution or exaggeration of true treatment effects due to heterogeneous trial designs and patient populations.
free
Original Research
Jul 2
Alessandro Beneduce, Dariusz Dudek, et al.
This ex vivo study evaluated the feasibility and outcomes of chimney stenting during redo-TAVI, finding that interactions between the coronary stents and the index TAV frames or aortic wall led to stent distortion and underexpansion, which could compromise procedural efficacy and future coronary access.
Trending articles
Myocardial infarction with non-obstructive coronary artery disease
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study
Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study
Management of complications after valvular interventions
Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)
State-of-the-Art Review
10.4244/EIJ-D-21-00426
•
Dec 3, 2021
Lindahl B et al
free
Focus article
10.4244/EIJY19M08_01
•
Jan 17, 2020
Glikson M et al
free
Clinical research
10.4244/EIJ-D-23-00326
•
Aug 7, 2023
Haude M et al
free
Clinical research
10.4244/EIJ-D-19-00128
•
Jun 12, 2019
Cresti A et al
free
State-of-the-Art
10.4244/EIJ-D-24-00066
•
Apr 21, 2025
Bansal A et al
free
Original Research
10.4244/EIJ-D-24-00055
•
Sep 16, 2024
Seguchi M et al
Expert consensus
10.4244/EIJ-D-24-00876
•
May 20, 2025
Paradies V et al
open access
Expert consensus
10.4244/EIJ-D-24-00876
•
Jun 16, 2025
Paradies V et al
free
Original Research
10.4244/EIJ-D-25-00331
•
May 21, 2025
Jang Y et al
open access
CLINICAL RESEARCH
10.4244/EIJ-D-17-00634
•
Nov 20, 2017
Zocca P et al
free
Expert consensus
10.4244/EIJ-D-24-00954
•
Jun 2, 2025
Nielsen-Kudsk J et al
free
